FRP Advisory Group plc (FRA:6S6)
Germany · Delayed Price · Currency is EUR | Market Cap | 299.59M -26.6% |
| Revenue (ttm) | 184.13M +9.9% |
| Net Income | 26.08M -12.9% |
| EPS | 0.10 -15.8% |
| Shares Out | n/a |
| PE Ratio | 11.49 |
| Forward PE | 8.95 |
| Dividend | 0.06 (5.55%) |
| Ex-Dividend Date | Feb 19, 2026 |
| Volume | n/a |
| Average Volume | 288 |
| Open | 1.140 |
| Previous Close | 1.170 |
| Day's Range | 1.140 - 1.140 |
| 52-Week Range | 1.100 - 1.740 |
| Beta | n/a |
| RSI | 43.24 |
| Earnings Date | Feb 13, 2026 |
About FRP Advisory Group
FRP Advisory Group plc, together with its subsidiaries, provides business advisory services to companies, lenders, investors, individuals, and other stakeholders in the United Kingdom. The company’s corporate finance advisory services include mergers and acquisitions (M&A), strategic advisory and valuations, capital raising, special situations M&A, partial exits, and financial due diligence; and debt advisory services comprise asset based lending, raising and refinancing debt, debt amendments and extensions, restructuring debt, and corporate an... [Read more]
Financial Performance
In fiscal year 2025, FRP Advisory Group's revenue was 152.20 million, an increase of 18.72% compared to the previous year's 128.20 million. Earnings were 22.50 million, an increase of 2.27%.
Financial numbers in GBP Financial StatementsNews
FRP Advisory Group a bargain in a booming market
FRP Advisory Group's past and future growth isnt reflected in the companys valuation
Cancer test firm Oncologica looking to raise cash
Cambridge-based Oncologica has hired consultants FRP Advisory to tap potential investors for £6 million.